| 000 | 01783 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517190243.0 | ||
| 264 | 0 | _c20180726 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1950-6007 | ||
| 024 | 7 |
_a10.1016/j.biopha.2017.11.100 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShi, Xiaoli | |
| 245 | 0 | 0 |
_aSelective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells. _h[electronic resource] |
| 260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cDec 2017 |
||
| 300 |
_a1186-1192 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDihydropyridines _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance _xdrug effects |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aG2 Phase Cell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSmall Molecule Libraries _xpharmacology |
| 700 | 1 | _aQin, Tiantian | |
| 700 | 1 | _aLiu, Weihua | |
| 700 | 1 | _aZhang, Xueyan | |
| 700 | 1 | _aLi, Leilei | |
| 700 | 1 | _aHuo, Junfeng | |
| 700 | 1 | _aZhou, Kairui | |
| 700 | 1 | _aYang, Dongxiao | |
| 700 | 1 | _aZhang, Yanling | |
| 700 | 1 | _aWang, Cong | |
| 773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 96 _gp. 1186-1192 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2017.11.100 _zAvailable from publisher's website |
| 999 |
_c27845392 _d27845392 |
||